RetractedArticleThe Journal of biological chemistry2016

Protein Phosphatase PP5 Controls Bone Mass and the Negative Effects of Rosiglitazone on Bone through Reciprocal Regulation of PPARγ (Peroxisome Proliferator-activated Receptor γ) and RUNX2 (Runt-related Transcription Factor 2).

Lance A Stechschulte et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.